Wendall Wierenga - Director at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Wendall Wierenga since 11/5/2023

Holdings reported by Wendall Wierenga for Crinetics Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 109K $5.19M $47.49 Jun 7, 2024 Direct
Stock Option (right to buy) 12.5K Jun 7, 2024 Direct Common Stock

Transactions reported by Wendall Wierenga for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.